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gress, leaving anti-Src antibodies in their wake (Brugge
and Erickson, 1977). The v-Src protein was subse-
quently shown by the Erikson and Bishop labs to have
protein kinase activity, a finding that was intuitively ap-
pealing because protein phosphorylation seemed a logi-
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cal way in which a single polypeptide could exert suchCanada
a pervasive influence on the cell (Levinson et al., 1978;
Collett and Erikson, 1978). Initial phosphoamino acid
analysis suggested that the relevant modification mightOver the last two decades, a new and unifying concept
be phosphothreonine.of cellular organization has emerged in which modular
So things stood until Tony Hunter, working with Walterprotein-protein interactions provide an underlying frame-
Eckhart in 1979, explored the biochemical properties ofwork through which signaling pathways are assembled
an entirely different viral oncogene product, the enig-and controlled. In this scheme, posttranslational mod-
matic polyomavirus middle T antigen (PyMT). Primedifications such as phosphorylation commonly exert
with the idea that viral oncoproteins might be proteintheir biological effects by regulating molecular inter-
kinases, Hunter tested immunoprecipitates of PyMT foractions, exemplified by the ability of phosphotyrosine
kinase activity and indeed found that PyMT itself be-sites to bind selectively to SH2 domains. Although
came phosphorylated in such an assay. More impor-these interactions are rather simple in isolation, they
tantly, he identified the phosphorylated amino acid ascan nonetheless be exploited to generate complex
phosphotyrosine (pTyr), a modification that had notcellular systems. Here, I discuss experiments that have
been previously found in proteins (Eckhart et al., 1979).led to this view of dynamic cellular behavior and iden-
Pursuing these observations, Hunter and Bart Seftontify some current and future areas of interest in cell sig-
found that v-Src itself has associated tyrosine kinasenaling.
activity, which induces an elevation in cellular tyrosine
phosphorylation and correlates with transformationThe Past
(Hunter and Sefton, 1980; Sefton et al., 1980). Later workTyrosine Phosphorylation
from Sara Courtneidge and Alan Smith showed thatThirty years ago, when I started my PhD, we lacked
PyMT is not itself a protein-tyrosine kinase but rathermost of the experimental and computational tools that
is a virally encoded scaffold that binds and activatesare now taken for granted. Fortunately, we had no idea
endogenous Src family kinases (Courtneidge and Smith,at the time of our sublime state of ignorance, or the very
1983) (Figure 1). Consistent with the findings regardingnotion of trying to understand the underlying princi-
PyMT, Owen Witte and David Baltimore reported in 1980ples of cellular organization and specificity in signal
that the v-Abl oncoprotein encoded by Abelson murinetransduction would have seemed like so much tilting at
leukemia virus becomes autophosphorylated on tyro-windmills. We did, however, have RNA and DNA viruses
sine in vitro (Witte et al., 1980). A preliminary answer tocapable of inducing malignant transformation, whose
the issue of v-Src function was therefore that it trans-genomes could be readily characterized. Their profound
forms cells through tyrosine phosphorylation.and rapid effects on the host cell suggested that they
In short order, a veritable avalanche of experimentscould teach us not only about malignancy, but also
suggested that the receptors for several growth factorsabout the properties of normal cells. For example, Rous
and insulin are tyrosine kinases, and that the aberrant
sarcoma virus (RSV) promotes changes in cell shape,
activation of such receptors, or ectopic expression of
adhesion, motility, growth, proliferation, gene expres-
their extracellular ligands, could induce cellular transfor-
sion, metabolism, and survival, raising the possibility mation (Ushiro and Cohen, 1980; Ek et al., 1982; Petruz-
that these distinct facets of cellular behavior might all zeli et al., 1982; Downward et al., 1984; Hunter and Coo-
be interconnected. Learning how a virus such as RSV per, 1981; Waterfield et al., 1983; Doolittle et al., 1983).
interacts with the cellular machinery might therefore re- Therefore, receptor tyrosine kinase (RTK) signaling is
veal unifying themes in cell biology. Indeed, work in important for the normal cellular response to mitogenic
the 1970s showed that the transforming activity of RSV and metabolic hormones, and the pathological activa-
could be mapped to a single viral gene (v-Src) (Martin, tion of such signaling pathways can provoke a cancer-
1970; Lai et al., 1973), which was shown by Michael ous phenotype. This raised the next critical issues—how
Bishop and Harold Varmus to represent a pirated copy do tyrosine kinases exert their effects on cellular behav-
of a normal cellular gene, c-Src (Stehelin et al., 1976). ior, and how is specificity maintained in signaling from
This reduced the problem to a deceptively simple ques- different receptors?
tion—what are the protein products of v-Src and similar Protein kinases were thought to achieve specificity
viral oncogenes, and what do they do? Joan Brugge through the ability of the active site of the kinase to
and Ray Erikson were the first to identify the elusive 60 recognize short motifs for phosphorylation (Kemp et
kDa v-Src protein by inoculating rabbits with a strain of al., 1975) and to employ phosphorylation to induce a
RSV that causes small tumors that subsequently re- conformational change in regulatory enzymes. This par-
adigm seemed sufficient to explain the regulation of
tyrosine kinases themselves. Ora Rosen found that*Correspondence: pawson@mshri.on.ca
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Figure 1. Molecular Organization of Signaling Proteins and Complexes
(A) The domain organization of the Fps, Src, and Abl cytoplasmic tyrosine kinases. FCH: Fps/Cip4 homology domain; CC: coiled coil; Pro:
proline-rich SH3 binding motifs; BD: binding domain. The sites of dipeptide insertions that led to the identification of the v-Fps SH2 domain
are shown by arrowheads.
(B) A signaling complex assembles around PyMT. This illustrates several concepts, including the ability of a scaffold to recruit a tyrosine
kinase and downstream targets, the ability of SH2 domains to distinguish different pTyr motifs, the capacity of serine phosphorylation to
create protein binding sites, and the formation of a signaling network through the reiterated use of modular interactions. A positive feedback
loop is evident in the ability of the Gab1 scaffold to both activate PI 3 kinase and respond to its product, PIP3, which binds the Gab1 PH
domain (Rodrigues et al., 2000). PTB  phosphotyrosine binding domain.
phosphorylation of purified insulin receptor stimulates for the oncogenic v-Fps/Fes cytoplasmic tyrosine ki-
nase, with the notion that we might locally disrupt theits in vitro kinase activity (Rosen et al., 1983); we pin-
pointed an autophosphorylation site within the kinase folding of globular domains and thus identify any non-
catalytic elements that regulate the kinase domain anddomain of the cytoplasmic v-Fps tyrosine kinase, a rela-
tive of Src and Abl, and showed that its substitution its interactions with cellular proteins (Stone et al., 1984).
with phenylalanine suppressed both v-Fps kinase and Mutations in the kinase domain led to an expected
transforming activities (Weinmaster et al., 1984). Cou- loss of catalytic and transforming activities. However,
pled with a body of work from Joseph Schlessinger through this approach we identified, in 1986, a region
showing that growth factors can activate receptors N-terminal to the kinase domain that was not required
through dimerization (e.g., Schreiber et al., 1983), such for catalytic activity per se but that modified both kinase
data indicated that transphosphorylation within the ca- activity and substrate recognition and was necessary
talytic domain stimulates tyrosine kinase activity. How- for cellular transformation (Sadowski et al., 1986). We
ever, the search for downstream substrates of tyrosine termed this element the Src homology 2 (SH2) domain
kinases produced the surprising result that the most because inspection of the sequences of the Src and Abl
abundant pTyr-containing protein in a growth factor- kinases revealed that the stretch of approximately 100
stimulated cell is usually the receptor itself. To us, this amino acids identified as functionally important by the
finding suggested that tyrosine phosphorylation might mutagenesis of v-Fps is conserved in Src and Abl and
have unsuspected biochemical functions, and that tyro- similarly positioned adjacent to the kinase (SH1) domain
sine kinases might have ways of recruiting their targets (Figure 1). Partial proteolysis indicated that the SH2 do-
in addition to the transient binding of a substrate to the main has a folded structure (Sadowski et al., 1986; Koch
active site of the enzyme. et al., 1989). These results suggested that specificity in
signaling by tyrosine kinases requires protein-protein
interactions that are mediated by a dedicated noncata-SH2 Domains and Protein-Protein Interactions
In pursuit of this idea, we introduced short dipeptide lytic domain (Sadowski et al., 1986; DeClue et al., 1987;
Koch et al., 1989). I proposed that the regulation of cellinsertions throughout the length of the coding sequence
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signaling by modular protein interactions might be a important in the deregulated signaling induced by onco-
genic tyrosine kinases (Matsuda et al., 1990; Mayer andmore general principle (Pawson, 1988), and indeed the
SH2 domain now serves as the prototype for a diverse Hanafusa, 1990). An answer to the question of how tyro-
sine kinases signal was therefore that tyrosine phos-collection of interaction domains that recognize not only
proteins but also phospholipids, nucleic acids, and small phorylation creates binding sites for proteins with SH2
domains. This led to the next problem—what is the mo-molecules (Pawson and Nash, 2003). This view of tyro-
sine kinase action has led to a new way of thinking about lecular basis for an SH2-pTyr interaction?
SH2 domains appeared to bind directly to pTyr sitescellular regulation, in which molecular interactions, me-
diated by protein interaction domains, provide a funda- (Margolis et al., 1990; Mayer et al., 1991; Escobedo et
al., 1991; Koch et al., 1992). In a seminal study in 1992,mental means of organizing signaling pathways and net-
works. John Kuriyan and Gabriel Waksman solved a structure
of the Src SH2 domain that revealed in molecular detailImportant support for this model came from the clon-
ing by Hidesaburo Hanafusa and Bruce Mayer of the how it recognizes the pTyr moiety of a phosphopeptide
(Waksman et al., 1992). This analysis uncovered severalviral Crk oncogene, which encodes a small protein com-
posed exclusively of an SH2 domain, and a second non- features that are now recognized as common themes
of many interaction domains. The SH2 domain itself hascatalytic element also found in Src and Abl that Hana-
fusa termed SH3 (Mayer et al., 1988). v-Crk associated a cassette-like design, with the N and C termini closely
juxtaposed in space, so that it can be inserted into awith a 130 kDa tyrosine phosphorylated protein (p130cas)
in transformed cells, raising the possibility that it acti- loop on a pre-existing polypeptide while leaving the
ligand binding surface exposed. The pTyr of a phospho-vates latent tyrosine kinase signals. At the same time,
cloning of cDNAs for the cytoplasmic signaling enzymes peptide ligand fits into a conserved pocket and is cap-
tured by an invariant arginine at the base of the pocket.phospholipase C (PLC) 1 and Ras GTPase activating
protein (GAP) revealed the presence of SH2 and SH3 These findings begged the question of how an SH2 do-
main can preferentially bind a specific pTyr-containingdomains, indicating that these domains might be com-
mon elements of seemingly disparate proteins (Stahl et sequence, exemplified by the ability of individual SH2
domains to select defined RTK autophosphorylational., 1988; Trahey et al., 1988; Vogel et al., 1988). Indeed,
PLC and RasGAP were found to be substrates for tyro- sites (Escobedo et al., 1991; Reedijk et al., 1992; Ronn-
strand et al., 1992). The basis for this discriminationsine kinases (Margolis et al., 1989; Meisenhelder et al.,
1989; Wahl et al., 1989; Molloy et al., 1989; Ellis et al., was suggested by Steven Shoelson in 1992, who used
synthetic phosphopeptides to show that the SH2 do-1990), and we also found that RasGAP associates induc-
ibly with other pTyr-containing proteins (Ellis et al., mains of the p85 subunit of PI 3 kinase bind preferen-
tially to phosphorylatyed YMXM motifs, indicating that1990). Such data were consistent with a scheme in which
SH2-containing proteins couple tyrosine kinase signals the sequence context of the tyrosine phosphorylation
site is important for SH2 domain recognition (Domchekto intracellular effectors such as the Ras GTPase and
phospholipid metabolism. et al., 1992).
The broader repertoire of SH2 binding specificity,In a parallel set of experiments, interest was gathering
around the idea that growth factor receptors might phys- however, remained mysterious until an elegant experi-
ment by Zhou Songyang and Lewis Cantley in 1993ically interact with their cytoplasmic targets and that
autophosphorylation of the receptor was important for (Songyang et al., 1993). Using an early example of a
proteomics approach, Cantley probed a degeneratethese interactions (Margolis et al., 1989; Kumjian et al.,
1989). In 1989, Jonathan Cooper and Andrius Kaz- peptide library, containing a fixed pTyr, with a large
number of SH2 domains. The results indicated that SH2lauskas found that autophosphorylation of the platelet-
derived growth factor  receptor on Tyr751 was impor- domains recognize residues C-terminal to the pTyr in a
fashion that varies from one domain to another, and thistant for the selective recruitment of phosphatidylinositol
(PI) 3 kinase (Kazlauskas and Cooper, 1989). Joining provided a general classification for SH2 domains based
on their phosphopeptide binding preferences. Signifi-these two lines of research, on RTK signaling and SH2-
containing proteins, we found in 1990 that the isolated cantly, known SH2 binding sites showed a remarkable
consonance with motifs identified in the library screen,SH2 domains of proteins such as PLC-1, RasGAP, and
Src have the common property of binding specifically to typified by the finding that the SH2 domain of the Grb2
adaptor binds phosphorylated YXN sequences (Song-autophosphorylated RTKs and tyrosine-phosphorylated
cytoplasmic proteins following growth factor stimulation yang et al., 1994) (Figure 1). Not only did Cantley’s tech-
nique provide a set of preferred residues at each position(Anderson et al., 1990; Moran et al., 1990). These data
showed that SH2 domains are independently folding of an SH2 binding site, it also identified residues that are
disfavored. This is important, as selectivity in modularmodules that provide otherwise distinct proteins with
the ability to specifically bind pTyr-containing RTKs and protein interactions stems from a combination of per-
missive and nonpermissive forces, both of which con-intracellular docking proteins following growth factor
stimulation. We found that different isolated SH2 do- tribute to biological specificity within the cell (e.g., Lar-
ose et al., 1993; Kay et al., 1998; Zarrinpar et al., 2003b).mains had distinct binding preferences for pTyr-con-
taining proteins, leading us to conclude that the specific- The identification of preferred SH2 binding motifs al-
lowed the primary sequences of proteins such as RTKsity of SH2-ligand interactions determines which signaling
proteins associate within a growth factor-stimulated cell to be scanned for potential SH2 domain interaction sites
(Yaffe et al., 2001), and this bioinformatic approach has(Moran et al., 1990). Meanwhile, the Hanafusa lab showed
that recombinant v-Crk mediates the pTyr-dependent been widely useful in predicting modular protein-protein
interactions.recognition of varied proteins from transformed cells,
consistent with the theme that such interactions are Pursuing these investigations into SH2 binding prefer-
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ences, Waksman and Kuriyan solved the structure of 2001; Ivan et al., 2001; Marmorstein, 2001; Hicke and
the Src SH2 domain bound to an optimal phosphopep- Dunn, 2003). In a more general context, they provide
tide with a YEEI motif (Waksman et al., 1993). At the a framework for the protein machines and interaction
same time, Michael Eck and Steven Harrison reported networks that organize cellular behavior.
the structure of the SH2 domain of the Src family kinase
Lck, also bound to a phosphorylated YEEI peptide (Eck The Present
et al., 1993). These data revealed that SH2 domains have How do rather simple events, such as posttranslational
a second binding surface, more variable than the pTyr modifications and protein-protein interactions, yield spe-
binding pocket, that engages the C-terminal specificity cific biological responses in the crowded environment
residues. This concept has also proved to be wide rang- of the cell? Some general principles have started to
ing, in the sense that families of interaction domains emerge, building on the themes enunciated above.
often bind a core element in their peptide ligands (i.e., Trafficking and Location
pTyr in the case of SH2 and PTB domains, PXXP or Biological specificity requires that receptors and their
RXXK for SH3 domains, phosphothreonine for FHA do- cytoplasmic targets be delivered to the appropriate site
mains) and achieve specificity through the variable rec- in the cell so that they are activated at the right time
ognition of flanking amino acids (Pawson and Nash, and in the right place. Cell surface receptors, for exam-
2000). Indeed, somewhat surprisingly, we found that it ple, can be directed to specific compartments of the
was possible to change the binding properties of an plasma membrane through selective binding of their
SH2 domain by substitution of a predicted specificity C-terminal motifs to the PDZ domains of polarity pro-
residue and thus to alter its biological activity in an intact teins. In C. elegans, the EGF receptor LET-23 is sorted
organism (Marengere et al., 1994). to the basolateral surface of epithelial cells through an
The generality of these ideas was supported by an association with the PDZ domain of the adaptor protein
exploration of SH3 domains. The yeast S. cerevisiae has LIN-7 (Kaech et al., 1998). Lin-7 also regulates the baso-
28 SH3 domains that function in pathways controlling lateral location of human ErbB RTKs in epithelial cells,
events such as osmosensing, cytoskeletal organization, first by delivering the receptor to the basolateral surface
and polarity, but lacks conventional tyrosine kinases through an interaction with the kinase domain and in
and SH2 domains (Tong et al., 2002). SH2 domains make addition by stabilizing the receptor at this site through
an evolutionary appearance in protozoa and Dictyoste- PDZ binding to the C terminus (Shelly et al., 2003). Hu-
lium discoideum, coincident with the emergence of con- man airway epithelial cells express both the ErbB2/4
ventional tyrosine kinases (Kawata et al., 1997; King et RTKs and their ligand Heregulin, but localize Heregulin
al., 2003). This suggested that SH3 domains evolved to to the apical surface so that it is segregated from its
regulate basic aspects of cellular organization and were receptors by cellular tight junctions until polarity is dis-
later co-opted by SH2-containing proteins to link newly turbed, for example, by damage to the epithelial mono-
evolved pTyr signals to SH3-regulated pathways. In layer (Vermeer et al., 2003). Thus, location of ligand and
1993, David Baltimore’s lab found that SH3 domains receptor control when and where signaling takes place.
bind preferentially to proline-rich motifs (Ren et al.,
Loss of cell polarity, or overexpression of a receptor
1993), and this has led to an extensive pursuit of the
such as ErbB2 in breast cancer, can abrogate the fine
varied structures, binding properties, and functions of
control imposed by spatial restrictions, activating sig-
SH3-containing proteins and to the identification of a
naling pathways at the wrong time and in the wronglarger family of domains that recognize proline-rich se-
place.quences (i.e., WW, EVH1, GYF domains) (Zarrinpar et
Because the duration of a signal can also be criticalal., 2003a).
for the nature of the cellular response, mechanisms mustIn sum, receptors with intrinsic tyrosine kinase activ-
exist to attenuate receptor signaling. Once activated,ity, or with associated cytoplasmic tyrosine kinase
RTKs are internalized in clathrin-coated vesicles andsubunits, mediate the effects of hormones, cytokines,
can traffic through endosomes to the multivesicularadhesion molecules, guidance cues, and antigens and
body and thus to the lysosome for degradation (Figureare aberrantly activated in a range of human cancers
3). This process involves a series of regulated protein-(Hunter, 2000; Schlessinger, 2000). They signal through
protein and protein-phospholipid interactions that in ag-SH2 proteins; the synergy between tyrosine kinase and
gregate form a rather sophisticated machinery. Initially,SH2 domains extends to the therapeutic arena since
a pTyr motif on the activated receptor binds to the SH2the kinase inhibitor Gleevec selectively recognizes a
domain of the E3 protein-ubiquitin ligase c-Cbl, leadingconformation of the autoinhibited Abl catalytic domain
to monoubiquitination of the receptor at multiple sitesthat is imposed by the adjacent SH2 domain (Nagar et
(Joazeiro et al., 1999; Haglund et al., 2003; Mosessonal., 2003). The ability of RTKs to recognize specific tar-
et al., 2003). The monoubiquitinated receptor can thengets through regulated protein-protein interactions has
be recognized by endocytic proteins with ubiquitin inter-proven to be a very general feature of specificity in
action motifs (UIM), such as epsin, and be recruited intosignaling from cell surface receptors (Figure 2) and intra-
budding vesicles (Polo et al., 2002; Shih et al., 2002).cellular cues (Pawson and Scott, 1997). Consistent with
Epsin also has an ENTH domain that binds PI(4,5)P2, aour original identification of the SH2 domain in the con-
phospholipid enriched in the plasma membrane, in atext of pTyr signaling, interaction modules can recognize
fashion that induces a new  helix in the ENTH domain.numerous protein modifications (including phosphoryla-
This helix has a hydrophobic outer surface that is in-tion, methylation, acetylation, hydroxylation, and ubiqui-
serted into the outer leaflet of the membrane bilayer,tination), and in this sense, they control the dynamic
state of the cell (Yaffe and Elia, 2001; Jaakkola et al., thereby triggering deformation of the membrane re-
Review
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Figure 2. Cell Surface Receptors Signal through Modular Protein Interactions
Many receptors bind intracellular targets and regulators through interaction domains, typified by the binding of RTK autophosphorylation
sites to SH2 domains, such as those on adaptor proteins. The TGFßR1 serine/threonine kinase recruits the MH2 domain of R-Smad proteins
through juxtamembrane autophosphorylation sites. Proline-rich motifs and their cognate interaction domains (i.e., SH3, EVH1) are employed
in diverse settings, such as binding of the yeast osmosensor Sho1 to the MAP kinase kinase/scaffold Pbs2 and recruitment of cytoskeletal
regulators such as Mena and srGAP1 to the axon guidance receptor Robo. Domains that form homo- or hetero-oligomers are commonly used
to recruit and cluster the targets of death and inflammatory receptors, such as Fas and Toll-like receptors (TLR). These receptors couple
through multidomain adaptors to targets such as initiator caspases or IRAK kinases/scaffolds (which in turn bind the Traf6 adaptor). G protein-
coupled receptors (GPCR), in addition to conventional signaling through heterotrimeric G proteins, can recruit multifunctional scaffolding
proteins that control receptor internalization, association with targets, and interactions with other receptors. Examples include -arrestin,
which binds many GPCRs and in turn interacts with the endocytic machinery and cytoplasmic signaling pathways. GPCRs can also interact
through their C termini with the PDZ domains of adaptor proteins, which in turn scaffold multiple signaling proteins or position the receptor
adjacent to ion channels. Details have been omitted for the sake of clarity. DD  death domain; DED  death effector domain; green bilobe 
kinase domain, MH  MAD homology, EVII  Ena/Vasp homology, TIR  Toll/IL-1 receptor domain.
quired for invagination and vesicle formation (Stahelin proteins is maintained through their modular interac-
tions with distinct membrane phosphoinositides. Mono-et al., 2003; Ford et al., 2002).
UIM-containing proteins can induce their own mono- ubiquitinated cargo is transferred to Hrs/Vps27 and then
to three successive multiprotein complexes (ESCRT-I,ubiquitination, potentially generating a network of low-
affinity UIM-mediated interactions that support endo- -II, and –III) before being internalized into the multivesic-
ular body of late endososmes (Katzmann et al., 2001,cytic trafficking (Polo et al., 2002). Indeed, the receptor
for monoubiquitinated cargo on endosomes (Hrs/Vps27) Katzmann et al., 2003; Bache et al., 2003). Not only are
Hrs-mediated interactions important for the physiologi-has a UIM domain (Shih et al., 2002; Raiborg et al., 2003;
Katzmann et al., 2002) and also a FYVE domain that cal downregulation of cell surface receptors (Jekely and
Rorth, 2003), but they can also be subverted to easeselectively binds PI(3)P, a phospholipid enriched in the
endosomal compartment (Burd and Emr, 1998; Raiborg the passage of viruses out of infected cells. Intriguingly,
enveloped viruses such as HIV and Ebola have hijackedet al., 2001). Thus spatial segregation of UIM trafficking
Cell
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Figure 3. Simplified Illustration of Protein-Protein and Protein-Phospholipid Interactions during Internalization of a Receptor
CB: clathrin binding region; Ub: ubiquitin; Tsg101: Ubiquitin and Hrs binding component of the ESCRT-I complex; MVB: endosome multivesicu-
lar body.
this endosomal network to promote budding from the pathway involves the localization of TGF receptors to
caveolin-positive vesicles in lipid rafts at the plasmaplasma membrane, a process that can be viewed as
similar to internalization into late endosomes (Garrus et membrane and recruitment of inhibitory proteins that
induce receptor ubiquitination and degradation. In thisal., 2001; Martin-Serrano et al., 2001). The HIV Gag pro-
tein interacts directly with the trafficking machinery, in cell signaling system, the specialized scaffold SARA di-
rects receptors to an internal site for signaling and awaypart by mimicking an interaction motif in Hrs/Vps27 (Por-
nillos et al., 2003; von Schwedler et al., 2003; Strack et from the pathway for downregulation. In a related vein,
distinct scaffolding proteins may target components ofal., 2003). The ability of pathogens to reorganize cellular
behavior by recruiting a network of regulatory proteins the Erk MAP kinase pathway to either the plasma mem-
brane or late endosomes, resulting in differential Erkto an inappropriate location speaks to the plasticity of
cellular signaling systems. activation at these sites. For example, the endosomal
p14 adaptor appears to recruit the MP1 scaffold withThe trafficking of receptors has stimulated debate as
to whether a component of receptor-mediated signaling its associated MEK1 and Erk1 kinases, thereby eliciting
Erk1 activation at late endosomes (Teis et al., 2002),occurs on internal membranes (Gonzalez-Gaitan and
Stenmark, 2003), as appears to be the case for TGF whereas the KSR scaffold stimulates the Erk MAP kinase
pathway at the plasma membrane (Muller et al., 2001).receptor serine/threonine kinases (Di Guglielmo et al.,
2003). These receptors recruit and phosphorylate Similar issues surround the sites of activation of Ras
GTPases. These proteins act as molecular switches,R-Smads (e.g., Smad2) and induce an R-Smad/Smad4
complex that is retained in the nucleus to regulate gene through the exchange of GDP for GTP and, once in the
GTP bound state, can potentially interact with one of aexpression. This process is facilitated by a scaffolding
protein, SARA, that binds to R-Smads and the activated number of targets. A prominent pathway from RTKs to
Ras involves recruitment of the Grb2 SH2/SH3 adaptorreceptor, as well as to PI(3)P through a FYVE domain.
The TGF receptor is recruited into clathrin-coated vesi- and the associated guanine nucleotide exchange factor
(GEF) Sos, which elicits activation of Ras at the plasmacles and sorted to EEA1-positive endosomes. The reten-
tion of TGF receptors in endosomes requires binding membrane. Another pathway to Ras activation requires
the SH2-containing phospholipase C-, which cleavesof the FYVE domain of SARA to PI(3)P and stimulates
signaling through the Smad2/4 pathway. An alternative PI(4,5)P2 to yield diacylglycerol and IP3, with the latter
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inducing release of calcium from intracellular stores. ulated through protein-protein interactions analogous
to those identified in tyrosine kinase signaling. This prin-This stimulates a calcium/diacylglycerol-sensitive Ras
GEF (RasGRP1) that localizes through a C1 domain to ciple is exemplified by Polo serine/threonine protein
kinases, such as Plk1, that play multiple roles duringgolgi and potentially induces selective Ras activation at
the golgi membrane (Bivona et al., 2003). Simultane- mitosis. Plk1 has an N-terminal kinase domain that pref-
erentially phosphorylates E/D-X-S/T-φ motifs and aously, the calcium-sensitive RasGAP CAPRI inhibits Ras
activation at the plasma membrane and thus accentu- C-terminal Polo box domain (PBD) that binds phosphor-
ylated S-pS/pT-P sequences (Elia et al., 2003a, 2003b;ates the stimulatory effect of RasGRP1 at the golgi.
These two pathways may therefore activate separate Cheng et al., 2003). Phosphopeptide binding to the PBD
simultaneously activates the kinase and targets it topools of Ras at the plasma membrane or golgi, which
could interact with different effectors or stimulate a com- cellular substrates (i.e., Cdc25C) that have been pre-
viously phosphorylated by a proline-directed kinasemon pathway at distinct locations or with different kinet-
ics. While there is still much debate about these ideas, such as Cdc2/cyclin B. This provides an elegant means
to couple the activities of distinct kinases in a complexthe spatial segregation of signaling pathways is likely
to be an important topic for the future. process such as cell division (Figure 4). In outline, this
mechanism is remarkably similar to cytoplasmic tyro-Docking Sites and Scaffolds
The early work on RTKs and SH2 domains suggested sine kinases such as Src and Abl, in which the SH2 and
SH3 domains maintain the kinase in an autoinhibitedthat tyrosine kinases select their targets through noncat-
alytic docking interactions. SH2 proteins can then be state but target the activated kinase to substrates.
The requirement for scaffolds to translate rather gen-activated by juxtaposition to substrates at the mem-
brane, by a conformational change induced by SH2 eral signals into specific biological responses becomes
particularly acute for enzymes regulated by a diffusiblebinding, or by phosphorylation once tethered to a tyro-
sine kinase. Similar mechanisms are employed by pro- second messenger, such as cAMP. A paradigm is pro-
vided by A-kinase anchoring proteins (AKAPs). Thesetein-serine/threonine kinases, which can bind docking
sites on their targets and then select compatible motifs are large polypeptides with the common ability to bind
the regulatory RII or R1 subunits of cAMP-dependentfor phosphorylation within the anchored substrate. Al-
ternatively, such kinases can employ dedicated sub- protein kinase (PKA) and thus to hold PKA in an inactive
state, from which the active catalytic subunit can bestrate binding subunits, or the kinase and its substrate
can associate with a common scaffold. MAP kinases, released by cAMP (Michel and Scott, 2002). AKAPs have
two other important properties. First, they have targetingfor example, bind docking motifs on their substrates,
regulators, and scaffolds in a way that confers pathway motifs that bind to subcellular determinants or recep-
tors. Furthermore, they possess binding sites for otherspecificity (Holland and Cooper, 1999; Sharrocks et al.,
2000). Structural analysis of the p38 MAP kinase reveals signaling enzymes, including protein kinase C (PKC) and
the phosphatase PP2B (Bauman and Scott, 2002). Ana docking groove in the C-terminal lobe of the kinase
for the motif R/K-X4-φ-X-φ, found in substrates such AKAP therefore provides a signaling hub that can be
localized to a specific site in a cell and through theas the MEF2A transcription factor and regulators such
as the kinase MKK3b (Chang et al., 2002). Of interest, combined activity of its associated partners can convert
a generic cAMP signal into a specific localized response,this interaction induces a conformational change in the
active site and activation segment of the kinase, sug- which is integrated with other regulatory inputs.
A further sophistication is that the same AKAP scaf-gesting that docking may be coupled to regulation of
kinase activity. fold can employ distinct binding partners to regulate
different ion channels in neurons. AKAP-79/150 is re-The active conformation of cyclin-dependent kinases
(CDK) is dependent on the association of a regulatory cruited to the GluR1 subunit of AMPA receptors by
MAGUK adaptor proteins and as a consequence local-cyclin subunit with the kinase. However, cyclins also
provide selective docking sites for substrates and regu- izes PKA and PP2B to regulate phosphorylation of
Ser845 in the tail of the receptor; this in turn determineslators, as in the case of cyclin A, which binds through
a hydrophobic patch to RXL motifs in targets (e.g., p107, the stability and surface expression of the channel (Col-
ledge et al., 2000, 2003). In contrast, the same AKAP-E2F-1) and inhibitors (e.g., p21, p27) (Schulman et al.,
1998). Extending this concept, the protein kinase mTOR, 79/150 is recruited to membranes in the vicinity of M
type KCNQ2 potassium channels by binding to PI(4,5)P2which integrates external and intrinsic signals that con-
trol cell growth, is targeted to substrates through scaf- and suppresses the inhibitory M current by facilitating
channel phosphorylation by PKC (Hoshi et al., 2003).folds, such as the WD40 repeat protein Raptor (Kim et
al., 2002; Hara et al., 2002). Raptor interacts with the Such observations emphasize that signaling by protein
kinases involves the physical tethering of the kinase andmTOR kinase and a conserved TOR signaling (TOS) mo-
tif on substrates such as 4E-BP1 and S6 kinase that substrate at a defined site in the cell and highlight the
dynamic nature and combinatorial possibilities of signal-regulate protein synthesis (Schalm et al., 2003; Schalm
and Blenis, 2002; Nojima et al., 2003). These interactions ing scaffolds.
Switches, Timing, Memory, and Asymmetryare complex since Raptor has been reported to sup-
press mTOR kinase activity when nutrients are limiting For cells to function, biochemical pathways must inte-
grate multiple signals, incorporate a temporal dimen-(Kim et al., 2002), while an additional motif (RAIP) is
important for 4E-BP1 phosphorylation (Choi et al., 2003; sion, and yet preserve an ability to react in a decisive
fashion. Regulation of actin polymerization and branchingBeugnet et al., 2003).
These data indicate that both the activity and the by the modular WASP/N-WASP proteins provides an
example of such complex regulation. The isolated Csubstrate specificity of serine/threonine kinases are reg-
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Figure 4. Regulation of the Plk1 Serine/Threonine Kinase by the Polo Box Domain, Containing Two Polo Motifs
The inhibitory interaction between the Polo box doamin and the kinase domain is relieved by phosphopeptide binding, which also targets the
kinase to its substrates.
terminus of WASP interacts constitutively with the ing the phosphorylated regulator and advancing the cell
cycle. One example of this mechanism involves Sic1,Arp2/3 complex to promote actin polymerization and
branching, but this is inhibited in the full-length protein an inhibitor of S phase CDK activity in the yeast S.
cerevisiae. Phosphorylation of Sic1 on Ser/Thr sites byby an intramolecular interaction with the N terminus
(Caron, 2002). This inhibition can be relieved by binding the G1 CDK leads to its recognition by an SCF ubiquitin
ligase complex, and consequent ubiquitination and deg-of the Cdc42 GTPase to a binding domain (GBD) in the
N-terminal regulatory region, which induces a conforma- radation, permitting entry into S phase. However, bind-
ing to the Cdc4 component of the SCF complex requirestional reorganization that liberates the active C terminus
(Kim et al., 2000). Furthermore, this activation is greatly at least six Sic1 phosphorylation sites, and this may
necessitate sustained G1 CDK activity (Nash et al.,potentiated by binding of PIP2 to a basic region preced-
ing the GBD, and the SH3 domains of SH2/SH3 adaptors 2001). Multisite phosphorylation of Sic1 may therefore
provide a timing device for progression through thecan also stimulate WASP activity (Rohatgi et al., 2000,
2001). It has been argued WASP is an AND gate, in cell cycle.
A transient signal may also be converted into an irre-that it only fires effectively in the presence of multiple
converging signals (Prehoda et al., 2000). Such an ar- versible, sustained response through a positive feed-
back loop (Xiong and Ferrell, 2003). Such a process hasrangement can suppress noise and allow the cell to
make switch-like responses. Of interest, artificial pro- been proposed to mediate the induction of cell asymme-
try and polarity in S. cerevisiae by the Cdc42 GTPase.teins containing the N-WASP C terminus flanked ectopi-
cally by heterologous interaction domains and binding In this scheme, GTP bound Cdc42 binds and opens
up the scaffold protein Bem1, which has a series ofmotifs can exhibit a range of switch-like responses, in-
cluding cooperative behavior (Dueber et al., 2003). This interaction domains (PB1, SH3, PX) that direct its associ-
ation with a guanine nucleotide exchange factor (GEF)supports the notion that proteins with complex proper-
ties can evolve by combining simple catalytic and inter- for Cdc42, downstream polarity proteins, and phospho-
inositides. The cycling of Cdc42, promoted by the acti-action domains within a single polypeptide. The native
WASP protein can also be regulated by phosphorylation vated GEF, and cooperative interactions between re-
cruited polarity proteins themselves can potentiallyat Y291 within the GBD. Y291 phosphorylation requires
prior Cdc42 binding but stabilizes actin polymerizing establish a positive feedback loop that induces a single
supramolecular assembly at the plasma membrane toactivity following dissociation of the Cdc42 GTPase (Tor-
res and Rosen, 2003). Torres and Rosen have therefore polarize the cytoskeleton and break cellular symmetry
(Irazoqui et al., 2003).argued that Y291 phosphorylation detects coincident
Cdc42 and tyrosine kinase inputs to WASP and drives Affinity and Specificity
In signaling networks, there is no optimal affinity fora long-lived response to transient agonists, thereby en-
dowing WASP with a form of molecular memory. protein-protein interactions, but rather a wide range of
dissociation constants that are tailored for distinct formsTransitions through the cell cycle provide a useful
testing ground for these ideas since these must only of biological regulation. It is natural to assume that tight
protein-protein interactions yield a high degree of speci-occur at the right time and under the right conditions,
but be irreversible. Here, phosphorylation of a key pro- ficity and are more biologically relevant than interactions
with relatively weak affinities. Strong interactions aretein may monitor the activity of a cell cycle kinase, while
polyubiquitination provides a means of rapidly destroy- long lived, and this can be advantageous, as in the
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tethering of inactive PKA to an AKAP in readiness for a Figure S1 at http://www.cell.com/cgi/content/full/116/
2/191/DC1).cAMP signal. However, such interactions cannot always
provide the flexibility that a cell needs to respond dy- Although the rules that underlie cellular networks have
yet to be clearly established, clues have started tonamically to changing external conditions or internal
programs. Indeed, protein-protein interactions that are emerge from an analysis of yeast transcription factors
(Lee et al., 2002). Importantly, the integration of large-dependent on posttranslational modifications must by
definition have relatively modest affinities since much scale proteomic data with transcriptional analysis, and
with genetic interactions, promises to be a powerful aidof the binding energy must come from the modified
residue itself (Bradshaw et al., 2000). However, affinities in understanding how cells work in normal and disease
states and may provide new avenues for manipulatingin the micromolar range do not necessarily mean an
absence of specificity. Indeed for both SH2 and SH3 cellular function that are therapeutically valuable (Wal-
hout et al., 2002).domains, increased affinity for a particular motif can
(somewhat paradoxically) come at the expense of speci- Present proteomic studies give us only a rather static
picture of a cellular environment that is in reality extraor-ficity (Kessels et al., 2002; Zarrinpar et al., 2003b). A
resolution to this conundrum may be that enhanced dinarily dynamic. It will be intriguing and important to
learn in more detail the extent to which signaling proteinsbinding to an optimal sequence may at the same time
interfere with a barrier to recognition of ectopic motifs assemble in distinct combinations in different cells and
even within a single cell. This type of analysis will requireand thus decrease specificity.
The yeast osmosensor Sho1, for example, has a single cell biochemistry, new analytical techniques to
follow the changing composition of multiprotein com-C-terminal cytoplasmic SH3 domain that binds to a pro-
line-rich motif in the scaffold (and kinase) Pbs2 (Figure plexes in living cells, and computational modeling to
extract the biological meaning of dynamic behavior (Lee2) in a fashion that is required for activation of the Hog1
MAP kinase in response to high salt. Recent data indi- et al., 2003). Imaging of the movement, interactions, and
locations of proteins in living cells will become especiallycate that Pbs2 binds specifically in vitro and in vivo to
the Sho1 SH3 domain if tested against the entire set of important; small fluorescent probes such as semicon-
ductor quantum dots, which can be used to track proteinyeast SH3 domains. However, it is rather promiscuous
if presented with metazoan SH3 domains. The Sho1 dynamics over extended periods in vivo, will likely prove
valuable in this regard (Dahan et al., 2003).SH3-Pbs2 interaction is therefore not optimized for affin-
ity, but rather has apparently been selected for specific- Understanding the rules by which cells operate, and
co-operate, raises the intriguing possibility of buildingity in the context of competing SH3-mediated interac-
tions within the yeast cell (Zarrinpar et al., 2003b). While new cellular functions. Thus, one can envisage a new
era of synthetic biology, in which the cell’s own regula-specificity in vivo apparently can be generated through
simple binary interactions, it is likely that many signaling tory and organizational prowess is harnessed to treat
disease.complexes utilize multiple contacts to ensure fidelity
(Bardwell et al., 2001). To this end, individual domains
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